Bath & Body Works, Inc. (BBWI)

NYSE Consumer Discretionary Other Specialty Retail S&P MidCap 400
$21.36
-0.72 (-3.26%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Thu, Nov 19, 2026
Before market open · quarter ending Oct/2026
Consensus EPS estimate
$0.11
9 analysts · year-ago EPS $0.35
Trailing 12-month EPS
$3.79
Diluted, last four reported quarters

Latest results, in brief

All BBWI 8-K briefs →
Aug 26, 7:17 AM ET

Bath & Body Works Q2 EPS of $0.58 beats guidance; full-year EPS outlook raised

Mixed earnings Written later 2.027.01

Bath & Body Works reported second-quarter 2026 net sales of $1,514 million, down 2.3% from a year earlier, while diluted earnings per share rose to $0.58 from $0.30. The company raised its full-year 2026 diluted EPS guidance to $3.13 to $3.33 and narrowed its net sales decline forecast to 4% to 2.5%, but the quarter included about $80 million of tariff refunds, and third-quarter EPS guidance of $0.05 to $0.10 is below the $0.37 reported a year earlier.

  • Q2 2026 net sales of $1,514 million, down 2.3% from $1,549 million; Direct net sales rose 3.0% to $275 million
  • Q2 diluted EPS of $0.58 vs. $0.30; adjusted EPS of $0.62 vs. $0.37. Excluding about $80 million of tariff refunds, adjusted EPS would have been $0.31
  • Full-year 2026 diluted EPS guidance raised to $3.13 to $3.33; adjusted EPS guidance $2.60 to $2.80; net sales guidance narrowed to a decline of 4% to 2.5%
  • Q3 2026 diluted EPS guidance of $0.05 to $0.10 (adjusted $0.07 to $0.12) vs. $0.37 (adjusted $0.35) in Q3 2025
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Aug 2026$1.51B-2.3% $0.58+93.3% $118.00M7.8%
May 2026$1.38B-3.2% $0.90+83.7% $183.00M13.3%
Jan 2026$2.72B-2.3% $1.94-5.8% $403.00M14.8%
Nov 2025$1.59B-1.0% $0.37-24.5% $77.00M4.8%
Aug 2025$1.55B+1.5% $0.30-55.9% $64.00M4.1%
May 2025$1.42B+2.9% $0.49+28.9% $105.00M7.4%
Feb 2025$2.79B-4.3% $2.06-18.6% $453.00M16.3%
Nov 2024$1.61B+3.1% $0.49-5.8% $106.00M6.6%

From Bath & Body Works, Inc.'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2026$7.29B-0.2% $3.11-13.9%8.9%
FY2025$7.31B-1.6% $3.61-6.0%10.9%
FY2024$7.43B-1.7% $3.84+12.0%11.8%
FY2023$7.56B-4.1% $3.43-29.7%10.6%
FY2022$7.88B+22.5% $4.88+62.7%16.9%

Frequently asked questions

When is Bath & Body Works's next earnings date?

Bath & Body Works (BBWI) is scheduled to report on Thursday, November 19, 2026 before the market opens. Analysts expect EPS of $0.11.

What did Bath & Body Works earn last quarter?

For the quarter ended Aug 2026, Bath & Body Works reported diluted EPS of $0.58 (+93.3% year over year) on revenue of $1.51B (-2.3%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.